Chromatin Remodeling Factor LSH is Upregulated by the LRP6-GSK3β-E2F1 Axis Linking Reversely with Survival in Gliomas. - Wikidata - wikimedia - TriplyDB

Chromatin Remodeling Factor LSH is Upregulated by the LRP6-GSK3β-E2F1 Axis Linking Reversely with Survival in Gliomas.

Chromatin Remodeling Factor LSH is Upregulated by the LRP6-GSK3β-E2F1 Axis Linking Reversely with Survival in Gliomas.

http://www.wikidata.org/entity/Q37541852

about

EGLN1/c-Myc Induced Lymphoid-Specific Helicase Inhibits Ferroptosis through Lipid Metabolic Gene Expression Changes Chromatin remodeling factor lymphoid-specific helicase inhibits ferroptosis through lipid metabolic genes in lung cancer progression.Decrease in Lymphoid Specific Helicase and 5-hydroxymethylcytosine Is Associated with Metastasis and Genome Instability.Baicalin hydrate inhibits cancer progression in nasopharyngeal carcinoma by affecting genome instability and splicing.Activation of AhR with nuclear IKKα regulates cancer stem-like properties in the occurrence of radioresistance.Long non-coding RNA linc01433 promotes migration and invasion in non-small cell lung cancer.Chromatin remodeling protein HELLS is upregulated by inactivation of the RB-E2F pathway and is nonessential for osteosarcoma tumorigenesis

P2860

Q41239680-CC022588-238E-452A-A0E0-8D1A869D8FF6 Q42690415-54F13073-9B6E-4C40-BB85-80335AC0F8A4 Q44727719-BC6245D8-76F7-4A81-B2C2-AFE1B16F8417 Q50043017-860C380F-693D-4D05-8F47-A4FACEEA49F5 Q53070583-BB3A1952-44F7-47BC-B246-273E5D680652 Q55113967-E8CFD50B-C38A-49AD-B191-B0A596A04062 Q57753288-65021383-F70C-42BA-8B50-6E3552B86CE5

P2860

Chromatin Remodeling Factor LSH is Upregulated by the LRP6-GSK3β-E2F1 Axis Linking Reversely with Survival in Gliomas.

http://www.wikidata.org/entity/Q37541852

description

article científic

@ca

article scientifique

@fr

articolo scientifico

@it

artigo científico

@pt

bilimsel makale

@tr

scientific article published on January 2017

@en

vedecký článok

@sk

vetenskaplig artikel

@sv

videnskabelig artikel

@da

vědecký článek

@cs

name

Chromatin Remodeling Factor LS ...... sely with Survival in Gliomas.

@en

Chromatin Remodeling Factor LS ...... sely with Survival in Gliomas.

@nl

type

label

Chromatin Remodeling Factor LS ...... sely with Survival in Gliomas.

@en

Chromatin Remodeling Factor LS ...... sely with Survival in Gliomas.

@nl

prefLabel

Chromatin Remodeling Factor LS ...... sely with Survival in Gliomas.

@en

Chromatin Remodeling Factor LS ...... sely with Survival in Gliomas.

@nl

P1433

Q37541852-5A102682-AB82-471C-8047-2FDA59738081

P1476

Q37541852-AFCB5CC4-5333-4C61-A3A0-62794EB82331

P2093

Q37541852-0FB3D242-F4EE-485B-8DBF-AFE28BCD4DF0

Q37541852-18ECDF52-4EFD-42FB-A2D4-C145EDDF77A1

Q37541852-25AF8EFE-5EE6-4A83-AB4A-7C70C48BA9A5

Q37541852-2A50D4F6-5F7F-4F00-A3EF-9A8A505F53AA

Q37541852-4438403C-9594-4C8F-96EE-D03AA4B483A0

Q37541852-44DA388B-6CC5-4B06-A660-8F4D49661A75

Q37541852-4FCB374D-15A1-4EA6-9EAE-E3FE012F0FC6

Q37541852-5024AE6F-254A-4FF6-A1D5-E750958BFF33

Q37541852-800EA67F-64DD-4630-BADD-08A888CD091C

Q37541852-8CAAD3CF-A694-496E-922B-58BC5DB51009

P2860

Q37541852-01F23833-E0FD-46C1-9EA1-96E9B6B7DF47

Q37541852-069EDBDC-007A-4683-9C57-9D40E1C9569B

Q37541852-2156A186-286F-49ED-B485-05E5448AF32A

Q37541852-28E168D8-9758-447C-8707-846BA0A81817

Q37541852-2DC8DC05-F8DC-4F97-967A-9F7350C652A8

Q37541852-39232B7E-F730-42B1-9096-7E161CA45257

Q37541852-40A03FC2-94F6-4B78-977E-C53D3AD9CFA3

Q37541852-4160A000-0E27-4525-9BA9-0F4DD2FD4F9B

Q37541852-4728193F-EB4E-46B8-BE7D-49FE2B753BD8

Q37541852-4D8436A3-6080-47F4-8425-EA683AC53B90

P304

Q37541852-0C7B49E5-0734-4816-92F8-A4309077DAD5

P31

Q37541852-BE207AC9-C818-4C79-BC36-2F566602790B

P356

Q37541852-04AD4455-18C2-476F-8371-BE148FF74539

P433

Q37541852-14E447CA-B96F-4074-94D6-A3E2774DF1BC

P478

Q37541852-9B9DFC47-7A6D-4BF3-9A0C-636FC7DD2A53

P577

Q37541852-52B13E27-D669-4319-B44C-05B9BCB31CEF

P698

Q37541852-3547CC80-FBE7-43CE-95A2-E5C0395FA6B4

P932

Q37541852-F51F8E46-F716-4CA7-B566-0FBA0316DF65

P356

P1433

P1476

Chromatin Remodeling Factor LS ...... sely with Survival in Gliomas.

@en

P2093

Chao Mao

http://www.w3.org/2001/XMLSchema#string

Chunyan Fu

http://www.w3.org/2001/XMLSchema#string

Desheng Xiao

http://www.w3.org/2001/XMLSchema#string

Hao Li

http://www.w3.org/2001/XMLSchema#string

Jianhua Zhou

http://www.w3.org/2001/XMLSchema#string

Jun Huang

http://www.w3.org/2001/XMLSchema#string

Ling Chen

http://www.w3.org/2001/XMLSchema#string

Rui Yang

http://www.w3.org/2001/XMLSchema#string

Shuang Liu

http://www.w3.org/2001/XMLSchema#string

Ya Cao

http://www.w3.org/2001/XMLSchema#string

P2860

The SNF2-like helicase HELLS mediates E2F3-dependent transcription and cellular transformation

Wnt/beta-catenin signaling: components, mechanisms, and diseases

Exciting new advances in neuro-oncology: the avenue to a cure for malignant glioma

Oncometabolite 2-hydroxyglutarate is a competitive inhibitor of α-ketoglutarate-dependent dioxygenases

Crystal structure of glycogen synthase kinase 3 beta: structural basis for phosphate-primed substrate specificity and autoinhibition

Structural and Functional Studies of LRP6 Ectodomain Reveal a Platform for Wnt Signaling

Structural basis of GSK-3 inhibition by N-terminal phosphorylation and by the Wnt receptor LRP6

Comprehensive, Integrative Genomic Analysis of Diffuse Lower-Grade Gliomas.

Wnt/beta-catenin signaling in development and disease

Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma

P304

132-143

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.7150/THNO.17032

http://www.w3.org/2001/XMLSchema#string

P433

1

http://www.w3.org/2001/XMLSchema#string

P478

7

http://www.w3.org/2001/XMLSchema#string

P577

2017-01-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

28042322

http://www.w3.org/2001/XMLSchema#string

P932

5196891

http://www.w3.org/2001/XMLSchema#string